UK Markets closed
NIKKEI 225
27,693.65 +184.19 (+0.67%) HANG SENG
21,222.16 -438.31 (-2.02%) CRUDE OIL
73.63 +0.24 (+0.33%) GOLD FUTURES
1,878.20 +1.60 (+0.09%) DOW
33,817.48 -108.53 (-0.32%) BTC-GBP
19,128.52 -175.10 (-0.91%)
Akebia Therapeutics, Inc. (AKBA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 12:28PM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.45 |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 2.9300 |
| 52-week low 3 | 0.2410 |
| 50-day moving average 3 | 0.5173 |
| 200-day moving average 3 | 0.4021 |
Share statistics
| Avg vol (3-month) 3 | 1.89M |
| Avg vol (10-day) 3 | 2.31M |
| Shares outstanding 5 | 183.96M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 181.66M |
| % held by insiders 1 | 1.51% |
| % held by institutions 1 | 33.32% |
| Shares short (13 Oct 2022) 4 | 6.29M |
| Short ratio (13 Oct 2022) 4 | 4.83 |
| Short % of float (13 Oct 2022) 4 | 3.46% |
| Short % of shares outstanding (13 Oct 2022) 4 | 3.42% |
| Shares short (prior month 14 Sept 2022) 4 | 7.71M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | -55.04% |
| Operating margin (ttm) | -38.91% |
Management effectiveness
| Return on assets (ttm) | -12.73% |
| Return on equity (ttm) | -137.90% |
Income statement
| Revenue (ttm) | 296.82M |
| Revenue per share (ttm) | 1.67 |
| Quarterly revenue growth (yoy) | 139.60% |
| Gross profit (ttm) | -17.92M |
| EBITDA | -77.69M |
| Net income avi to common (ttm) | -163.37M |
| Diluted EPS (ttm) | -2.7690 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 143.89M |
| Total cash per share (mrq) | 0.78 |
| Total debt (mrq) | 134.31M |
| Total debt/equity (mrq) | 215.59 |
| Current ratio (mrq) | 1.30 |
| Book value per share (mrq) | 1.67 |
Cash flow statement
| Operating cash flow (ttm) | -171.36M |
| Levered free cash flow (ttm) | -130.64M |
© 2023 Yahoo. All rights reserved.
